Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial
Academic Article
Publication Date:
2021
Short description:
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial / Szarek, Michael; Bhatt, Deepak L; Steg, Ph Gabriel; Cannon, Christopher P; Leiter, Lawrence A; Mcguire, Darren K; Lewis, Julia B; Riddle, Matthew C; Voors, Adriaan A; Metra, Marco; Lund, Lars H; Komajda, Michel; Testani, Jeffrey M; Wilcox, Christopher S; Ponikowski, Piotr; Lopes, Renato D; Banks, Phillip; Tesfaye, Eshetu; Ezekowitz, Justin A; Verma, Subodh; Pitt, Bertram. - In: ANNALS OF INTERNAL MEDICINE. - ISSN 1539-3704. - 174:8(2021), pp. 1065-1072. [10.7326/M21-0651]
abstract:
In the SOLOIST-WHF (Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure) trial, sotagliflozin, a sodium-glucose cotransporter-1 and sodium-glucose cotransporter-2 inhibitor, reduced total occurrences of cardiovascular deaths, hospitalizations for heart failure, and urgent visits for heart failure relative to placebo by 33%.
Iris type:
1.1 Articolo in rivista
Keywords:
Aged; Diabetes Mellitus; Type 2; Double-Blind Method; Female; Glycosides; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors
List of contributors:
Szarek, Michael; Bhatt, Deepak L; Steg, Ph Gabriel; Cannon, Christopher P; Leiter, Lawrence A; Mcguire, Darren K; Lewis, Julia B; Riddle, Matthew C; Voors, Adriaan A; Metra, Marco; Lund, Lars H; Komajda, Michel; Testani, Jeffrey M; Wilcox, Christopher S; Ponikowski, Piotr; Lopes, Renato D; Banks, Phillip; Tesfaye, Eshetu; Ezekowitz, Justin A; Verma, Subodh; Pitt, Bertram
Published in: